When the Number Falls, Everything You Built on Top of It Comes Due

Here is a story that looks like it is about finance. It is actually about revenue.

As Calcalist reported this week, Arieli bought a controlling stake in the tech investment company Elron in 2024 for $53 million. To finance it, Arieli took a $30 million loan, pledged against the very Elron shares it was buying. At the time, the stake was worth roughly twice the loan. Comfortable.

Then Elron's stock fell 34% since the start of the year. The collateral shrank. The loan-to-value covenant broke. The lender started shopping the pledged shares to buyers, reportedly at prices below the debt itself. And Arieli's three equal partners, according to Calcalist, publicly fractured over how to handle it.

That is what leverage does. It magnifies. When the number goes up, everyone looks like a genius. When it goes down, everything you built on top of it comes due at once, and it takes the relationships with it.

Valuation is borrowed confidence. Revenue is yours.

Strip the deal down and here is what it rested on: the belief that Elron's share price would hold. And a share price is just the market's bet on the future revenue of the companies underneath it. The moment that belief slipped, the collateral evaporated, because the collateral was never really the shares. It was confidence.

That is the trap. A valuation is not money in the bank. It is a number other people assign to your future, and they revise it the second they get nervous. Revenue is the opposite. Revenue is the thing that is actually yours, that shows up whether or not the market is in a good mood.

Founders do the same thing, just smaller

You do not need a $30 million loan to make this mistake. You make it every time you build on a number you have not yet proven you can produce repeatedly.

You raise at a valuation and start spending like the valuation is cash. You hire a team against a forecast nobody has stress-tested. You sign obligations, leases, roadmaps, partner promises, all pinned to revenue that is still a hope, not a machine. As long as the number climbs, it all holds together and everyone is aligned. The day it stalls, the debt, the hires and the partnership all present their bill on the same morning.

Growth papers over everything. A stalled number exposes everything.

The company that did it the other way

Compare this to BioCatch, which went from $7M to a $2.4 billion Visa exit. That was not financial engineering. It was a repeatable revenue machine that produced the same result across markets, over and over, until a buyer paid a fortune for the certainty of it. Nobody had to pledge anything and hope.

The difference between the two stories is the difference between building value and borrowing it.

What to actually do

The time to build a revenue engine you can forecast is before the downturn, not during it. That means a pipeline you can actually trust, a motion that produces deals without heroics, and a number one person owns and answers for. That is not a nice-to-have you get to after the raise. It is the only thing that makes the raise, the debt and the partnership survivable when the market turns, and the market always turns.

If your business is currently held up by a valuation, a loan or a forecast that only works if everything goes right, that is not a strategy. That is a bet. A fractional CRO builds the thing underneath it that is actually yours.